IRIS
CALO', Girolamo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 21.715
EU - Europa 4.901
AS - Asia 2.682
SA - Sud America 26
OC - Oceania 13
Continente sconosciuto - Info sul continente non disponibili 11
AF - Africa 1
Totale 29.349
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 21.672
CN - Cina 1.690
UA - Ucraina 1.376
DE - Germania 917
TR - Turchia 865
IT - Italia 695
GB - Regno Unito 633
BE - Belgio 407
FI - Finlandia 322
SE - Svezia 319
PL - Polonia 87
FR - Francia 50
RU - Federazione Russa 48
VN - Vietnam 48
CA - Canada 42
IN - India 19
IR - Iran 16
AT - Austria 15
BR - Brasile 12
CL - Cile 11
JP - Giappone 11
HK - Hong Kong 7
NZ - Nuova Zelanda 7
A2 - ???statistics.table.value.countryCode.A2??? 6
AU - Australia 6
KR - Corea 6
EU - Europa 5
NL - Olanda 4
SG - Singapore 4
DK - Danimarca 3
GR - Grecia 3
HR - Croazia 3
LU - Lussemburgo 3
RO - Romania 3
BG - Bulgaria 2
CH - Svizzera 2
IQ - Iraq 2
NO - Norvegia 2
YE - Yemen 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
AR - Argentina 1
BD - Bangladesh 1
BS - Bahamas 1
CZ - Repubblica Ceca 1
EC - Ecuador 1
EE - Estonia 1
ES - Italia 1
IE - Irlanda 1
IL - Israele 1
KH - Cambogia 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
MC - Monaco 1
MD - Moldavia 1
MM - Myanmar 1
MY - Malesia 1
NP - Nepal 1
PE - Perù 1
PH - Filippine 1
SA - Arabia Saudita 1
TH - Thailandia 1
ZA - Sudafrica 1
Totale 29.349
Salva come PNG Salva come JPEG
Città #
Fairfield 3.304
Woodbridge 2.875
Houston 1.966
Jacksonville 1.586
Ann Arbor 1.518
Ashburn 1.393
Chandler 1.387
Seattle 1.336
Wilmington 1.179
Cambridge 1.156
Izmir 545
Nanjing 454
Brussels 405
Princeton 353
Beijing 352
San Diego 279
Ferrara 272
Boardman 240
Milan 179
Nanchang 136
Dearborn 127
Shenyang 126
Falls Church 92
Hebei 82
Warsaw 82
San Mateo 81
Norwalk 78
Jiaxing 74
Bremen 73
Tianjin 73
Changsha 66
Redwood City 64
Mountain View 63
Jinan 54
London 54
Auburn Hills 48
Addison 47
Dong Ket 45
Munich 43
Philadelphia 42
Kunming 41
Washington 40
Zhengzhou 40
Helsinki 39
Mcallen 30
Guangzhou 29
Montréal 29
Tappahannock 28
Des Moines 27
Los Angeles 27
Orange 27
Indiana 26
Ningbo 26
Shanghai 21
Fuzhou 20
Verona 20
Lanzhou 19
New York 19
Bologna 18
Redmond 18
Augusta 16
Leawood 16
Hanover 15
Hangzhou 13
Padova 10
Taizhou 10
Vienna 10
Ardabil 9
Düsseldorf 9
Toronto 9
Changchun 8
Islington 8
Walnut 7
Chiswick 6
Ferrara di Monte Baldo 6
Hefei 6
San Francisco 6
Bari 5
Haikou 5
La Canada Flintridge 5
Monmouth Junction 5
New Bedfont 5
Yellow Springs 5
Boston 4
Central District 4
Edinburgh 4
Florence 4
Moscow 4
Adelaide 3
Baltimore 3
Changping 3
Chicago 3
Dallas 3
Hanoi 3
Hyderabad 3
Innsbruck 3
Köln 3
Luxembourg 3
Mumbai 3
Portici 3
Totale 23.123
Salva come PNG Salva come JPEG
Nome #
Chimeric G proteins in fluorimetric calcium assays: Experience with opioid receptors 230
null 205
AGONISTI PIENI E PARZIALI ED ANTAGONISTI DEL RECETTORE PER NOCICETTINA/ORFANINA FQ AD ELEVATA POTENZA” 178
A diastereoselective synthesis of Cebranopadol, a novel analgesic showing NOP/mu mixed agonism 165
Structural Bacterial Molecules as Potential Candidates for an Evolution of the Classical Concept of Probiotics 159
[(pF)Phe4,Arg14,Lys15]N/OFQ-NH2 (UFP-102), a highly potent and selective agonist of the nociceptin/orphanin FQ receptor 158
Characterization of FR 172357, a new non-peptide bradykinin B2 receptor antagonist, in human, pig and rabbit preparations 149
A novel and facile synthesis of tetra branched derivatives of nociceptin/orphanin FQ. 144
A new selective antagonist of the nociceptin receptor 141
Structure-activity studies on the nociceptin/orphanin FQ receptor antagonist 1-benzyl-N-{3-[spiroisobenzofuran-1(3H),4'-piperidin-1-yl]propyl} pyrrolidine-2-carboxamide. 140
Structure activity studies of nociceptin/orphanin FQ(1–13)-NH2 derivatives modified in position 5 137
Kinin B-1 and B-2 receptors in pig vessels: characterization of two monoreceptor systems 136
[Nphe(1),Arg(14),Lys(15)]nociceptin-NH2, a novel potent and selective antagonist of the nociceptin/orphanin FQ receptor 136
N- and C-terminal modifications of nociceptin/orphanin FQ generate highly potent NOP receptor ligands 136
Intrathecal administration of nociceptin/orphanin FQ receptor agonists in rats: A strategy to relieve chemotherapy-induced neuropathic hypersensitivity 132
Beta-arrestin 2 rather than G protein efficacy determines the anxiolytic- versus antidepressant-like effects of nociceptin/orphanin FQ receptor ligands 132
Pharmacological characterization of nociceptin receptor: an in vitro study 132
Emergency admissions of opioid drug-abusers for overdose. A chronobiological study of enhanced risk 131
Exploring pharmacological activities and signaling of morphinans substituted in position 6 as potent agonists interacting with the μ opioid receptor 131
Human vascular kinin receptors of the B-2 type characterized by radioligand binding 131
Cell and tissue responses of a range of Urotensin II analogs at cloned and native urotensin II receptors. Evidence for coupling promiscuity 130
Tryptophan replacement in the nociceptin/orphanin FQ receptor ligand Ac-RYYRWK-NH2 130
Conformation-activity relationship of neuropeptide S and some structural mutants: Helicity affects their interaction with the receptor 130
[D-Pen(p-tBuBzl)5]NPS, a novel ligand for the neuropeptide S receptor: structure activity and pharmacological studies 129
Nociceptin/orphanin FQ induces simultaneously anxiolytic and amnesic effects in the mouse elevated T-maze task. 128
Behavioural phenotypic characterization of CD-1 mice lacking the neuropeptide S receptor 128
[Dmt(1) ]N/OFQ(1-13)-NH(2) , a potent nociceptin/orphanin FQ and opioid receptor universal agonist. 128
In vitro pharmacological characterisation of a novel cyclic nociceptin/orphanin FQ analogue c[Cys(7,10)]N/OFQ(1-13)NH2 126
A new ligand for the urotensin II receptor 125
Pharmacological profile of nociceptin/orphanin FQ receptors interacting with G-proteins and β-arrestins 2 125
Anxiolytic- and panicolytic-like effects of Neuropeptide S in the mouse elevated T-maze. 124
Characterisation of the novel mixed Mu-NOP peptide ligand dermorphin-N/OFQ (DeNo) 124
Synthesis and biological activity of human neuropeptide S analogues modified in position 2 123
Cardiovascular effects of nociceptin in unanesthetized mice 122
Ring size in cyclic endomorphin-2 analogs modulates receptor binding affinity and selectivity 121
A staged screening of registered drugs highlights remyelinating drug candidates for clinical trials 121
Pharmacology of [Tyr(1)]nociceptin analogs: receptor binding and bioassay studies 120
Genetic and pharmacological evidence that endogenous nociceptin/orphanin FQ contributes to dopamine cell loss in Parkinson's disease 120
Nociceptin/Orphanin FQ Receptor Structure, Signaling, Ligands, Functions, and Interactions with Opioid Systems 119
Antidepressant activity of nociceptin/orphanin FQ receptor antagonists in the mouse learned helplessness 118
Genetic Deletion of the Nociceptin/Orphanin FQ Receptor in the Rat Confers Resilience to the Development of Drug Addiction 118
The Importance of Ligand-Receptor Conformational Pairs in Stabilization: Spotlight on the N/OFQ G Protein-Coupled Receptor 118
In vitro and in vivo studies on UFP-112, a novel potent and long lasting agonist selective for the nociceptin/orphanin FQ receptor 117
[Nphe(1)]nociceptin-(1-13)-NH2 antagonizes nociceptin effects in the mouse colon 117
Nociceptin/orphanin FQ receptor antagonists as innovative antidepressant drugs. 117
Acute and chronic antiparkinsonian effects of the novel nociceptin/orphanin FQ receptor antagonist NiK-21273 in comparison with SB-612111 117
Pharmacological studies on the NOP and opioid receptor agonist PWT2-[Dmt(1)]N/OFQ(1-13) 117
UFP-112 a Potent and Long-Lasting Agonist Selective for the Nociceptin/Orphanin FQ Receptor 116
Modulation of the NOP receptor signaling affects resilience to acute stress 116
Effects of vasoactive agents in healthy and diseased human saphenous veins 116
Structure-and conformation-Activity studies of nociceptin/orphanin FQ receptor dimeric ligands 116
Identification of an achiral analogue of J-113397 as potent nociceptin/orphanin FQ receptor antagonist 115
Structure-activity study of the nociceptin(1-13)-NH2 N-terminal tetrapeptide and discovery of a nociceptin receptor antagonist 115
Pharmacological characterization of the nociceptin/orphanin FQ receptor non peptide antagonist Compound 24. 115
[Nphe(1)]N/OFQ-(1-13)-NH2 is a competitive and selective antagonist at nociceptin/orphanin FQ receptors mediating K+ channel activation in rat periaqueductal gray slices 113
Structure-activity relationship study of position 4 in the urotensin-II receptor ligand U-II(4-11) 113
[(t)Bu-d-Gly(5)]NPS, a pure and potent antagonist of the neuropeptide S receptor: In vitro and in vivo studies 113
Effects of neuropeptide S on seizures and oxidative damage induced by pentylenetetrazole in mice. 113
Blockade of nociceptin/orphanin FQ-NOP receptor signalling produces antidepressant-like effects: pharmacological and genetic evidences from the mouse forced swimming test 113
AMPA receptor activation regulates the glutamate metabotropic receptor stimulated phosphatidylinositol turnover in human cerebral cortex slices 113
Pharmacological characterization of the nociceptin receptor mediating hyperphagia: identification of a selective antagonist 112
Synthesis and Biological Activity of Human Neuropeptide S Analogues Modified in Position 5: Identification of Potent and Pure Neuropeptide S Receptor Antagonists. 112
Electrocardiographic alterations as a result of acute intoxication with fluvoxamine and pipamperone 112
In vitro pharmacological characterization of a novel unbiased NOP receptor-selective nonpeptide agonist AT-403 112
Selective breeding for high anxiety introduces a synonymous SNP that increases neuropeptide s receptor activity 111
Endogenous nociceptin/orphanin FQ signalling produces opposite spinal antinociceptive and supraspinal pronociceptive effects in the mouse formalin test: Pharmacological and genetic evidences 110
Effects of chronic nociceptin/orphanin FQ exposure on cAMP accumulation and receptor density in Chinese, hamster ovary cells expressing human nociceptin/orphanin FQ receptors 110
UFP-101 antagonizes the spinal antinociceptive effects of nociceptin/orphanin FQ; Behavioral and electrophysiological studies in mice 110
null 110
Further studies on nociceptin-related peptides: Discovery of a new chemical template with antagonist activity on the nociceptin receptor 109
Role of nociceptin/orphanin FQ receptors in the decrease of mucosal mast cells caused by acute stress in the rat colon. 109
Structure-activity relationship study on Tyr9 of urotensin-II(4-11): identification of a partial agonist of the UT receptor. 108
Synthesis of mixed MOR/KOR efficacy cyclic opioid peptide analogs with antinociceptive activity after systemic administration 108
Assessment of the activity of a novel nociceptin/orphanin FQ analogue at recombinant human nociceptin/orphanin FQ receptors expressed in Chinese hamster ovary cells 107
[Nphe(1)]nociceptin-(1-13)NH2 selectively antagonizes nociceptin effects in the rabbit isolated ileum 107
Actual concept of "probiotics": is it more functional to science or business? 107
In vitro and in vivo pharmacological characterization of Pronetupitant, a prodrug of the neurokinin 1 receptor antagonist Netupitant 107
Nociceptin/orphanin FQ inhibits ischaemia-induced glutamate efflux from rat cerebrocortical slices 106
Simultaneous targeting of multiple opioid receptors: a strategy to improve side-effect profile. 106
Effects of human urotensin II in isolated vessels of various species; comparison with other vasoactive agents 106
In vitro and in vivo pharmacological characterization of the novel neuropeptide S receptor ligands QA1 and PI1 106
Address and message sequences for the nociceptin receptor: A structure-activity study of nociceptin-(1-13)-peptide amide 106
Dmt-Tic-NH-CH2-Bid (UFP-502), a potent DOP receptor agonist: In vitro and in vivo studies 105
Inhibitory effect of NMDA receptor activation on quisqualate-stimulated phosphatidylinositol turnover in the human cerebral cortex 105
Desensitisation of native and recombinant human urotensin-II receptors. 105
null 105
Activation of the nociceptin/orphanin FQ receptor reduces bronchoconstriction and microvascular leakage in a rabbit model of gastroesophageal reflux 104
Studies on the antinociceptive effect of [Nphe(1)]nociceptin(1-13)NH2 in mice 104
Characterization of nociceptin receptors in the periphery: in vitro and in vivo studies 104
Structure-activity study at positions 3 and 4 of human neuropeptide S. 104
Anxiolytic- and antidepressant-like activities of H-Dmt-Tic-NH-CH(CH2-COOH)-Bid (UFP-512), a novel selective delta opioid receptor agonist 104
Pharmacological characterization of tachykinin tetrabranched derivatives 104
Nociceptin/orphanin FQ exacerbates excitotoxic white-matter lesions in the murine neonatal brain 103
Pharmacological characterisation of novel kinin B2 receptor ligands 103
B1 and B2 kinin receptors in various species 103
null 103
Blockade of adenosine A2A receptor counteracts neuropeptide-S-induced hyperlocomotion in mice. 103
Urodynamic effects of intravesical nociceptin/orphanin FQ in neurogenic detrusor overactivity: A randomized, placebo-controlled, double-blind study 103
Immediate and delayed effects of in vitro ischemia on glutamate efflux from guinea-pig cerebral cortex slices 102
Central injections of nocistatin or its C-terminal hexapeptide exert anxiogenic-like effect on behaviour of mice in the plus-maze test 102
Totale 12.059
Salva come PNG Salva come JPEG
Categoria #
all - tutte 79.871
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.456
Totale 81.327
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20194.595 0 0 26 119 48 48 431 34 324 792 1.086 1.687
2019/20207.460 1.067 269 255 1.077 558 871 748 783 660 649 333 190
2020/20214.824 377 445 264 569 307 488 167 566 154 633 576 278
2021/20223.625 144 368 310 217 202 190 217 233 156 302 307 979
2022/20233.721 378 160 115 413 570 482 208 388 475 47 322 163
2023/2024652 212 343 97 0 0 0 0 0 0 0 0 0
Totale 29.804